Researchers determined patients with paroxysmal hemoglobinuria may benefit from receiving ravulizumab over the long term.

Due to its rarity, the exact incidence is unknown, however, it is estimated that the global prevalence is 15.9 individuals per one million people. The PIGA mutation in PNH causes red blood cells ...

The full set of implications of this observation, in terms of its potential role in the classification, epidemiology ... with particular situations, or paroxysmal. In the last case, when ...

Teva and Samsung Bioepis have launched Epysqli, a cost-saving Soliris biosimilar, offering a 30% discount and new hope for ...